Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$892M |
| 2 |
Merck
MRK
|
+$858M |
| 3 |
Amgen
AMGN
|
+$857M |
| 4 |
Home Depot
HD
|
+$837M |
| 5 |
Cisco
CSCO
|
+$781M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$776M |
| 2 |
United Parcel Service
UPS
|
+$615M |
| 3 |
Qualcomm
QCOM
|
+$587M |
| 4 |
Alibaba
BABA
|
+$555M |
| 5 |
Eaton
ETN
|
+$508M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Financials | 12.96% |
| 3 | Healthcare | 11.88% |
| 4 | Consumer Discretionary | 11.22% |
| 5 | Industrials | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Oric Pharmaceuticals
ORIC
$1.1B
| $2.81M | ﹤0.01% |
114,503
+4,790
| +4% | +$151K |
|
2552
PMV Pharmaceuticals
PMVP
$59.7M
| $2.8M | ﹤0.01% |
85,085
+1,921
| +2% | +$75.7K |
|
|
TECX
2553
Tectonic Therapeutic
TECX
$527M
| $2.8M | ﹤0.01% |
18,362
-52
| -0.3% | -$8.46K |
|
|
TPCO
2554
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $2.8M | ﹤0.01% |
155,385
+12,040
| +8% | +$195K |
|
|
KRON
2555
DELISTED
Kronos Bio
KRON
| $2.79M | ﹤0.01% |
95,361
+4,020
| +4% | +$118K |
|
2556
Black Diamond Therapeutics
BDTX
$99.7M
| $2.78M | ﹤0.01% |
114,506
+6,379
| +6% | +$172K |
|
|
MGI
2557
DELISTED
MoneyGram International, Inc. New
MGI
| $2.78M | ﹤0.01% |
422,589
+13,302
| +3% | +$97.4K |
|
2558
International Money Express
IMXI
$369M
| $2.77M | ﹤0.01% |
184,682
+7,723
| +4% | +$119K |
|
|
KNTE
2559
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $2.76M | ﹤0.01% |
+88,641
| New | +$3.09M |
|
|
EGIO
2560
DELISTED
Edgio, Inc. Common Stock
EGIO
| $2.75M | ﹤0.01% |
19,271
-1,095
| -5% | -$171K |
|
|
SPNE
2561
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $2.75M | ﹤0.01% |
157,765
+2,580
| +2% | +$46.3K |
|
|
BDSI
2562
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $2.74M | ﹤0.01% |
700,702
-3,987
| -0.6% | -$16.5K |
|
|
SYRS
2563
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $2.72M | ﹤0.01% |
36,317
+12,022
| +49% | +$1.25M |
|
|
CDMO
2564
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $2.71M | ﹤0.01% |
148,880
+11,873
| +9% | +$197K |
|
2565
Dorian LPG
LPG
$1.97B
| $2.71M | ﹤0.01% |
206,599
-19,687
| -9% | -$261K |
|
2566
Digimarc Corp
DMRC
$161M
| $2.71M | ﹤0.01% |
91,416
+9,023
| +11% | +$358K |
|
2567
UNIFI
UFI
$119M
| $2.71M | ﹤0.01% |
98,262
+2,278
| +2% | +$55K |
|
|
AMK
2568
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $2.71M | ﹤0.01% |
116,029
+4,002
| +4% | +$96.8K |
|
2569
Seneca Foods Class A
SENEA
$1.15B
| $2.71M | ﹤0.01% |
57,467
-76
| -0.1% | -$3.63K |
|
2570
Mercer International
MERC
$44.8M
| $2.7M | ﹤0.01% |
187,860
-249,510
| -57% | -$3.32M |
|
|
FLXN
2571
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $2.7M | ﹤0.01% |
301,855
+5,709
| +2% | +$65.4K |
|
2572
Grid Dynamics Holdings
GDYN
$553M
| $2.7M | ﹤0.01% |
169,534
-343
| -0.2% | -$4.93K |
|
2573
VSE Corp
VSEC
$5.81B
| $2.7M | ﹤0.01% |
68,319
+9,242
| +16% | +$361K |
|
|
LITS
2574
Lite Strategy Inc
LITS
$33.4M
| $2.69M | ﹤0.01% |
39,263
+428
| +1% | +$29.9K |
|
2575
Vaxcyte
PCVX
$7.73B
| $2.69M | ﹤0.01% |
136,178
+18,585
| +16% | +$468K |
|
Similar funds
Charles Schwab's Q1 2021 Portfolio in Review
As of Q1 2021, Charles Schwab held 3,565 positions worth $273B, up 8.3% from $252B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Charles Schwab's Q1 2021 filing shows 168 new, 2,233 increased, 898 reduced and 80 closed positions. Its largest new stake was State Street Financial Select Sector SPDR ETF: 6,984,918 shares worth $238M. The largest sale was ExxonMobil, an estimated $776M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2021 buy was State Street Financial Select Sector SPDR ETF: 6,984,918 shares worth $238M.
- Charles Schwab added most to Broadcom in Q1 2021, an estimated $892M increase.
- Charles Schwab's biggest Q1 2021 reduction was ExxonMobil, cutting an estimated $776M.
- Charles Schwab fully exited Invesco QQQ Trust in Q1 2021, selling an estimated $396M.
- Charles Schwab's ten largest holdings make up 16% of its $273B portfolio in Q1 2021.
- Charles Schwab opened 168 new positions and closed 80 in Q1 2021.
- Charles Schwab's portfolio value rose 8.3% quarter-over-quarter to $273B.
Based on Charles Schwab's 13F filing for Q1 2021, filed 17 May 2021.